![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » NIAID AND MEDIMMUNE JOIN FORCES TO DEVELOP POTENTIAL PANDEMIC INFLUENZA VACCINES
NIAID AND MEDIMMUNE JOIN FORCES TO DEVELOP POTENTIAL PANDEMIC INFLUENZA VACCINES
September 28, 2005
HHS Secretary Mike Leavitt today announced that the National Institute of Allergy
and Infectious Diseases (NIAID) and MedImmune Inc. have signed a cooperative
research and development agreement for the development of vaccines against avian
influenza viruses that have the potential to cause pandemics. Under the agreement,
NIAID, part of the National Institutes of Health, and MedImmune of Gaithersburg,
Md., will produce and test multiple vaccines against potential pandemic flu
strains, including the H5N1 avian influenza virus.
PR
Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct